An exceptional response to olaparib in relapsed and refractory BRCA2 mutated non-small cell lung cancer in hereditary breast-ovarian cancer syndrome

在遗传性乳腺癌-卵巢癌综合征中，复发和难治性 BRCA2 突变非小细胞肺癌对奥拉帕尼的反应异常显著。